title: [Adalimumab].
authors.affiliation: Service de dermatologie, CHU de Besançon, 2, place Saint-Jacques, 25030 Besançon cedex, France. francois.aubin@univ-fcomte.fr
authors.forename: F
authors.initials: F
authors.lastname: Aubin
authors.forename: H
authors.initials: H
authors.lastname: Barthelemy
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology; D016903:Drug Monitoring; D006801:Humans; D007239:Infections / Q000209:etiology; D009369:Neoplasms / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab